Therapeutic Drug Monitoring Journal Citation Rate 2026

ISSN 0163-4356 eISSN 1536-3694 Lippincott Williams & Wilkins US

Q2 Quartile

About Therapeutic Drug Monitoring
{# Self-contained "answer block": one dense, LLM-quotable paragraph stating every core fact with an explicit as-of year, server-rendered and unique per journal. This is the canonical fact statement — other sections add narrative, they do not restate these numbers. #}

Therapeutic Drug Monitoring (TDM) is a peer-reviewed academic journal, published by Lippincott Williams & Wilkins in US, catalogued under ISSN 0163-4356 (e-ISSN 1536-3694). As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 1.42 (Q2 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It operates a subscription model.

Therapeutic Drug Monitoring Citation Rate 2026 — In Context

Therapeutic Drug Monitoring has a 2025 2-Year Citation Rate (OpenAlex) of 1.42, placing it in the Q2 quartile. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.

Therapeutic Drug Monitoring operates a subscription-based publishing model — readers access articles through institutional subscriptions or pay-per-view.

Researchers looking to publish in Therapeutic Drug Monitoring should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare Therapeutic Drug Monitoring against similar journals in the field, use our journal comparison tool.

ISSN (Print) 0163-4356
ISSN (Online) 1536-3694
Publisher Lippincott Williams & Wilkins
Country United States
APC / Cost Inquire with Publisher
h-index 120
Total Works 6,785
Total Citations 135,488
2-yr Mean Citedness 1.63 (OpenAlex)
In-depth profile & metrics

Therapeutic Drug Monitoring is published by Lippincott Williams & Wilkins and based in United States.

Editorially, Therapeutic Drug Monitoring concentrates on Pharmacological Effects and Toxicity Studies, Antibiotics Pharmacokinetics and Efficacy and Renal Transplantation Outcomes and Treatments, within the broader field of Medicine.

Therapeutic Drug Monitoring is indexed in OpenAlex. OpenAlex tracking provides an open, citable record of its output even where commercial indexing is absent.

OpenAlex records 6,785 works that have together drawn 135,488 citations, giving the journal an h-index of 120; its most recent citation rate stands at 1.416; OpenAlex puts its two-year mean citedness at 1.63.

Links
Frequently Asked Questions about Therapeutic Drug Monitoring

Therapeutic Drug Monitoring does not hold a Clarivate (JCR) Impact Factor on JournalsHub. Its 2-year citation rate, computed from OpenAlex open citation data, is 1.416 — an open proxy for citation impact, not the licensed JCR Impact Factor.

No, Therapeutic Drug Monitoring is not an open access journal.

Therapeutic Drug Monitoring is published by Lippincott Williams & Wilkins.

Therapeutic Drug Monitoring shows strong legitimacy signals: it is indexed in OpenAlex. Indexing in recognised databases such as Scopus and DOAJ is a reliable indicator of a peer-reviewed, non-predatory journal, because predatory titles are typically excluded from them. Always confirm the journal's scope and editorial board fit your work before submitting.

The ISSN of Therapeutic Drug Monitoring is 0163-4356. Its electronic ISSN (eISSN) is 1536-3694.

Therapeutic Drug Monitoring sits in the Q2 quartile based on its latest impact factor of 1.42, ranked across all journals in our database.
Live Indexing Status
Updated April 2026

Track real-time indexing metrics to ensure this journal meets your academic requirements.

OpenAlex
Verified
DOAJ
Non-OA
Predatory Check
Clean
Citation Rate
1.416
2-Year Citation Rate (OpenAlex) · 2025
Historical Trend
Initial data points only
Citation Rate by Year
Year Value Source
2025 1.416 2-Year Mean Citedness (OpenAlex)

Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.


Works Published per Year (2014–2025)

Annual publication volume sourced from OpenAlex. Current year omitted (partial data).

Publication & citation history by year
YearWorks publishedCitations received
2025 129 150
2024 161 438
2023 111 798
2022 95 701
2021 91 1,281
2020 141 1,883
2019 130 3,031
2018 113 2,806
2017 100 1,948
2016 109 2,376
2015 100 1,973
2014 147 3,217
Journal at a Glance
6,785
Total Works
135,488
Total Citations
120
h-index
1.63
2-Yr Mean Citedness

Source: OpenAlex — refreshed daily.

Top Research Topics

The areas where Therapeutic Drug Monitoring most frequently publishes, ranked by article volume. Click a topic to see the best journals for it.

Metadata

Last updated: Apr 24, 2026

Updated by: openalex_bulk

OpenAlex ID: S179268941

Get weekly updates

Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.

Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now
Compare 0 Open → Clear
Save your viewing history
You've browsed several journals this session. Sign in to track them in one place and get weekly impact-factor updates.
Save with Google